Cell-Autonomous Function of Runx1 Transcriptionally Regulates Mouse Megakaryocytic Maturation

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Pencovich, Niv ^a   Jaschek, Ram ^a   Dicken, Joseph ^a   Amit, Ayelet ^a   Lotem, Joseph ^a   Tanay, Amos ^a   Groner, Yoram ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

E1A ASSOCIATED P300 PROTEIN; TRANSCRIPTION FACTOR ETS; TRANSCRIPTION FACTOR GATA; TRANSCRIPTION FACTOR NF E2; TRANSCRIPTION FACTOR RUNX; TRANSCRIPTION FACTOR RUNX1;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL SPECIFICITY; CHROMATIN IMMUNOPRECIPITATION; E1A ASSOCIATED P300 GENE; EMBRYO; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MUTATION; GENE STRUCTURE; GENE TARGETING; GENETIC TRANSFECTION; HOMEOSTASIS; MEGAKARYOCYTE; MOUSE; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; REGULATOR GENE; SELP GENE; SEQUENCE ANALYSIS; THROMBOCYTOPOIESIS; TRANSCRIPTION FACTOR ETS GENE; TRANSCRIPTION FACTOR GATA GENE; TRANSCRIPTION FACTOR NF E2 GENE; TRANSCRIPTION FACTOR RUNX GENE; TRANSCRIPTION FACTOR RUNX1 GENE; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELL DIFFERENTIATION; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; CORE BINDING FACTOR ALPHA 2 SUBUNIT; GENE EXPRESSION REGULATION; MEGAKARYOCYTES; MICE; MICE, KNOCKOUT; P300-CBP TRANSCRIPTION FACTORS; PRIMARY CELL CULTURE; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC;

EID: 84878161493     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064248     Document Type: Article

References (40)

1. De Brujin M, Speck NA, (2004) Core-binding factors in hematopoiesis and immune function. Oncogene 23: 4238-4248.
2. Asou N, (2003) The role of a Runt domain transcription factor AML1/RUNX1 in leukemogenesis and its clinical implications. Crit Rev Oncol Hematol 45: 129-150.
3. Greif PA, Konstandin NP, Metzeler KH, Herold T, Pasalic Z, et al. (2012) RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with poor prognosis and up-regulation of lymphoid genes. Haematologica.
4. Growney JD, Shigematsu H, Li Z, Lee BH, Adelsperger J, et al. (2005) Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood 106: 494-504.
5. Ichikawa M, Asai T, Saito T, Seo S, Yamazaki I, et al. (2004) AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat Med 10: 299-304.
6. Goldfarb AN, (2007) Transcriptional control of megakaryocyte development. Oncogene 26: 6795-6802.
7. Ben-Ami O, Pencovich N, Lotem J, Levanon D, Groner1 Yoram, (2009) A regulatory interplay between miR-27a and Runx1 during megakaryopoiesis. PNAS 106: 238-243.
8. Pencovich N, Jaschek R, Tanay A, Groner Y (2011) Dynamic combinatorial interactions of RUNX1 and cooperating partners regulates megakaryocytic differentiation in cell line models. Blood.
9. Song WJ, Sullivan MG, Legare RD, Hutchings S, Tan X, et al. (1999) Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukamia. Nat Genet 23: 166-175.
10. Speck N, Gilliland DG, (2002) Core-binding factors in haematopoiesis and leukaemia. Nat Rev Cancer 2: 502-513.
11. Lange B, (2000) The management of neoplastic disorders of haematopoiesis in children with Down's syndrome. Br J Haematol 110: 512-524.
12. Elagib KE, Racke FK, Mogass M, Khetawat R, Delehanty LL, et al. (2003) RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation. Blood 101: 4333-4341.
13. Goldfarb AN, (2009) Megakaryocytic programming by a transcriptional regulatory loop: A circle connecting RUNX1, GATA-1, and P-TEFb. J Cell Biochem 107: 377-382.
14. Eisman R, Surrey S, Ramachandran B, Schwartz E, Poncz M, (1990) Structural and functional comparison of the genes for human platelet factor 4 and PF4alt. Blood 76: 336-344.
15. Ravid K, Beeler DL, Rabin MS, Ruley HE, Rosenberg RD, (1991) Selective targeting of gene products with the megakaryocyte platelet factor 4 promoter. Proc Natl Acad Sci U S A 88: 1521-1525.
16. Tiedt R, Schomber T, Hao-Shen H, Skoda RC, (2007) Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo. Blood 109: 1503-1506.
17. Visel A, Blow MJ, Li Z, Zhang T, Akiyama JA, et al. (2009) ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457: 854-858.
18. Fock EL, Yan F, Pan S, Chong BH, (2008) NF-E2-mediated enhancement of megakaryocytic differentiation and platelet production in vitro and in vivo. Exp Hematol 36: 78-92.
19. Kim JA, Jung YJ, Seoh JY, Woo SY, Seo JS, et al. (2002) Gene expression profile of megakaryocytes from human cord blood CD34(+) cells ex vivo expanded by thrombopoietin. Stem Cells 20: 402-416.
20. Shivdasani RA, Schulze H (2005) Culture, expansion, and differentiation of murine megakaryocytes. Curr Protoc Immunol Chapter 22:Unit 22F 26.
21. Ainbinder E, Revach M, Wolstein O, Moshonov S, Diamant N, et al. (2002) Mechanism of rapid transcriptional induction of tumor necrosis factor alpha-responsive genes by NF-kappaB. Mol Cell Biol 22: 6354-6362.
22. Aziz-Aloya RB, Levanon D, Karn H, Kidron D, Goldenberg D, et al. (1998) Expression of AML1-d, a short human AML1 isoform, in embryonic stem cells suppresses in vivo tumor growth and differentiation. Cell Death Differ 5: 765-773.
23. Nguyen HG, Yu G, Makitalo M, Yang D, Xie HX, et al. (2005) Conditional overexpression of transgenes in megakaryocytes and platelets in vivo. Blood 106: 1559-1564.
24. McLean CY, Bristor D, Hiller M, Clarke SL, Schaar BT, et al. GREAT improves functional interpretation of cis-regulatory regions. Nat Biotechnol 28: 495-501.
25. Smith EC, Thon JN, Devine MT, Lin S, Schulz VP, et al. (2012) MKL1 and MKL2 play redundant and crucial roles in megakaryocyte maturation and platelet formation. Blood.
26. Halene S, Gao Y, Hahn K, Massaro S, Italiano JEz Jr, et al. (2010) Serum response factor is an essential transcription factor in megakaryocytic maturation. Blood 116: 1942-1950.
27. Wang Y, Meng R, Hayes V, Fuentes R, Yu X, et al. (2011) Pleiotropic platelet defects in mice with disrupted FOG1-NuRD interaction. Blood 118: 6183-6191.
28. Randrianarison-Huetz V, Laurent B, Bardet V, Blobe GC, Huetz F, et al. (2010) Gfi-1B controls human erythroid and megakaryocytic differentiation by regulating TGF-beta signaling at the bipotent erythro-megakaryocytic progenitor stage. Blood 115: 2784-2795.
29. Eckly A, Rinckel JY, Laeuffer P, Cazenave JP, Lanza F, et al. (2010) Proplatelet formation deficit and megakaryocyte death contribute to thrombocytopenia in Myh9 knockout mice. J Thromb Haemost 8: 2243-2251.
30. Kanaji T, Russell S, Cunningham J, Izuhara K, Fox JE, et al. (2004) Megakaryocyte proliferation and ploidy regulated by the cytoplasmic tail of glycoprotein Ibalpha. Blood 104: 3161-3168.
31. Petrich BG, Marchese P, Ruggeri ZM, Spiess S, Weichert RA, et al. (2007) Talin is required for integrin-mediated platelet function in hemostasis and thrombosis. J Exp Med 204: 3103-3111.
32. Tran DQ, Andersson J, Wang R, Ramsey H, Unutmaz D, et al. (2009) GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells. Proc Natl Acad Sci U S A 106: 13445-13450.
33. Zhang W, Colman RW, (2007) Thrombin regulates intracellular cyclic AMP concentration in human platelets through phosphorylation/activation of phosphodiesterase 3A. Blood 110: 1475-1482.
34. Shivdasani RA, (1996) The role of transcription factor NF-E2 in megakaryocyte maturation and platelet production. Stem Cells 14Suppl 1: 112-115.
35. Shivdasani RA, (2001) Molecular and transcriptional regulation of megakaryocyte differentiation. Stem Cells 19: 397-407.
36. Zingariello M, Fabucci M, Bosco D, Migliaccio A, Martelli F, et al. (2009) Differential localization of P-selectin and von Willebrand factor during megakaryocyte maturation. Biotech Histochem: 1-14.
37. Bee T, Ashley EL, Bickley SR, Jarratt A, Li PS, et al. (2009) The mouse Runx1 +23 hematopoietic stem cell enhancer confers hematopoietic specificity to both Runx1 promoters. Blood 113: 5121-5124.
38. Blow MJ, McCulley DJ, Li Z, Zhang T, Akiyama JA, et al. ChIP-Seq identification of weakly conserved heart enhancers. Nat Genet 42: 806-810.
39. May D, Blow MJ, Kaplan T, McCulley DJ, Jensen BC, et al. (2011) Large-scale discovery of enhancers from human heart tissue. Nat Genet 44: 89-93.
40. Vahedi G, Takahashi H, Nakayamada S, Sun HW, Sartorelli V, et al. STATs Shape the Active Enhancer Landscape of T Cell Populations. Cell 151: 981-993.